[{"indications": "Indications\u00a0reduction of sputum viscosity, \n(From 3.7 Mucolytics: British National Formulary)\n3.7 Mucolytics", "name": "CARBOCISTEINE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "3 Respiratory system", "3.7 Mucolytics", "CARBOCISTEINE"], "cautions": "Cautions\u00a0\n(From 3.7 Mucolytics: British National Formulary)\nMucolytics should be used with caution in those with a history of peptic ulceration because they may disrupt the gastric mucosal barrier.", "side-effects": "Side-effects\u00a0rarely gastro-intestinal bleeding;\r\nhypersensitivity reactions (including rash and anaphylaxis) also reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3063.htm", "doses": ["Initially 2.25\u00a0g daily in divided doses, then 1.5\u00a0g daily\r\nin divided doses as condition improves; child 2\u20135 years 62.5\u2013125\u00a0mg 4 times daily, 5\u201312 years 250\u00a0mg 3 times daily"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid in first trimester"}]